Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Recruiting now

Conditions studied: Cardiomyopathy

In brief

The objective of this study is to collect information on patients with cardiomyopathy (CM) due to mutations in the MYBPC3 gene, to evaluate their disease course, burden of illness, risk factors for this disease, and the quality of life (QoL). This study will also collect information on treatments, procedures and outcome in infants and children up to 18 yrs who have this mutation.

Key facts

Study ID
NCT05112237
Run by
Tenaya Therapeutics
People needed
200
Starts
2021-11-01
Expected to finish
2028-06-01
Last updated by the study team
2024-11-13

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.